their reactivity profiles have been extensively studied.6 It is
known that, under certain conditions, IAM and NSM can
modify other reactiveaminoacids (e.g., Lysand His).7 Asa
consequence, it has been suggested that the selection of the
thiol blocking reagent should not be arbitrary. Due to the
disparate reactivity of various thiols influenced by their
localization within the protein and physiological environ-
ment, one must consider the unique property of target
protein and necessary experimental conditions to select
proper thiol blocking agents.8
tested several commercially available 2-halogenated benzo-
thiazoles (3aꢀ3c). These compounds are known to react
with thiol at high temperature and under strong basic
conditions.10 However, under mild and biologically mimic
conditions, these substrates displayed very poor reactivity
and only a trace amount of the desired product 2a was
formed. The reaction using 2-diazo substrate 3d resulted
in a complicated mixture of products, and only a small
amount of 2a was produced (judging by TLC and crude
NMR). Interestingly, 2-methylsulfonyl benzothiazole
(MSBT) showed very high reactivity toward 1a, with
almost quantitative formation of 2a within 20 min. To
the best of our knowledge, this was the first example
illustrating the excellent reactivity of MSBT toward al-
kylthiols in aqueous solutions.
On the basis of all the above-mentioned, the develop-
ment of new thiol blocking reagents that possess distinctive
reactivity profiles from currently known compounds is
needed. Our consideration in this subject was to explore
molecules that could react with free thiols via nucleophilic
aromatic substitution (NAS). We developed this idea from
previous work in our laboratory that studied the reactions
of 2-mercaptobenzothiazole (2-SHBT) toward sulfen-
amides and alkyl disulfides.9 The results revealed that
2-SHBT was inert to disulfide exchange reactions but
showed significant reactivity against more reactive electro-
philes, i.e. sulfenamides. In contrast, other aromatic thiols
such as thiophenol, 2-mercaptopyridine, and 2-mercapto-
pyrimidine were found reactive to both alkyl disulfides and
sulfenamides. It should be noted that the disulfide ex-
change is a dynamic equilibrium and thus the progress of
the reaction is controlled by both the electrophilicity/
nucleophilicity of the starting disulfide/thiol pair as well
as those generated. These results suggest that the electron
withdrawing effect of the benzothiazole ring decreases the
reactivity of the corresponding thiol and inhibits disulfide
formation. We envisioned that by placing a leaving group
at the C-2 position, benzothiazole might be vulnerable for
nucleophilic attack by thiols via the NAS mechanism.
With this idea in mind, we designed a series of experiments
to examine whether the benzothiazole moiety could be
employed as an electrophilic trap for thiols and Cys
residues. Here we report our results.
Table 1. Reactions of Benzothiazole Substrates with Model
Substrate 1a
We first examined the reactivity of various benzothia-
zole substrates containing different leaving groups at the
C-2 position (Table 1). A cysteine derivative 1a was used as
a thiol model. In a typical experimental setting, to a
solution of 1a in 1:2 THF/phosphate buffer (200 mM,
pH = 7.4) were added 2 equiv of benzothiazole substrate
respectively. The reaction was monitored by TLC. We
We next investigated whether the pronounced reactivity
of MSBT 3e toward thiols could also occur with other
potential nucleophilic species found in proteins. A series of
amino acid derivatives (4aꢀ4f) were then tested under the
same conditions. As shown in Scheme 2, side chain func-
tionalities of serine, tyrosine, tryptophan, and methionine
are inert to MSBT (5 equiv). In addition, lysine and
histidine substrates (4e and 4f) did not react with MSBT
to form any product (monitored by TLC), even after 4 h.
These outcomes were expected, as known reactions of
MSBT with amines and alcohols require high temperature
and/or strong basic media.11 Nevertheless, these results
suggested that MSBT is a thiol-selective blocking reagent.
(6) (a) Chapter 2 Thiol-Reactive Probes. The Molecular Probes
Handbook: A guide to Fluorescent Probes and Labeling Technologies,
11th ed.; Johnson, I., Spence, M. T. Z., Eds.; Life Technologies Corporation:
2010; pp 97ꢀ116. (b) Hermanson, G. T. Bioconjugate Techniques, 2nd
ed.; Elsiever Inc., 2008; 1202 pp.
(7) (a) Yang, Z.; Attygalle, A. B. J. Mass Spectrom. 2007, 42, 233.
(b) Ying, J.; Claverul, N.; Sethraman, M.; Adachi, T.; Cohen, R. A. Free
Radical Biol. Med. 2007, 43, 1099.
(8) Hill, B. G.; Reily, C.; Oh, J.-H.; Jonhson, M. S.; Landar, A. Free
Radical Biol. Med. 2009, 47, 675.
(9) Pan, J.; Xian, M. Chem. Commum. 2011, 47, 352.
(11) (a) Kayoda, S.; Takamura, I.; Suzuki, N.; Dohmori, R. Chem.
Pharm. Bull. 1976, 24, 136. (b) Giesbrecht, H. E.; Knight, B. J.; Tanguileg,
N. R.; Emerson, C. R.; Blakemore, P. R. Synlett 2010, 3, 374.
(c) Nomoto, Y.; Takai, H.; Ohno, T.; Kubo, K. Chem. Pharm. Bull.
1991, 39, 352. (d) De Kock, H., Jonckers, T. H. M., Boonants, P. J. G. M.,
Last, S. J., Baumeister, J. E., Van’tklooster, G. A. E. PTC Int. Appl.
2007147884.
(10) (a) Naya, A.; Kobayashi, K.; Ishikawa, M.; Ohwaki, K.; Saeki,
T.; Noguchi, K.; Ohtake, N. Chem. Pharm. Bull. 2003, 51, 697. (b)
Lohmann, S.; Andrews, S. P.; Burke, B. J.; Smith, M. D.; Attfield, J. P.;
Tanaka, H.; Kaneko, K.; Ley, S. V. Synlett 2005, 8, 1291. (c) Chapelon,
A.-M.; Ollivier, C.; Santelli, M. Tetrahedron Lett. 2006, 47, 2747. Egi,
M.; Liebeskind, L. S. Org. Lett. 2003, 5, 801.
Org. Lett., Vol. 14, No. 13, 2012
3397